Recent development of multi-targeted inhibitors of human topoisomerase II enzyme as potent cancer therapeutics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent development of multi-targeted inhibitors of human topoisomerase II enzyme as potent cancer therapeutics

Published:2023-01 Issue: Volume:226 Page:473-484
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Singh Vishal,Afshan Tayyaba,Tyagi Pankaj,Varadwaj Pritish Kumar,Sahoo Amaresh Kumar

Funder

Department of Biotechnology, Ministry of Science and Technology, India

Indian Institute of Information Technology, Allahabad

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference123 articles.

1. Ovarian cancer today and tomorrow: a global assessment by world region and Human Development Index using GLOBOCAN 2020;Cabasag;Int. J. Cancer,2022

2. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis;de Martel;Lancet Glob. Health,2020

3. The World Cancer Declaration: time to consolidate wins and work towards 2025;Johnson;Lancet Oncol.,2021

4. Single-target versus multi-target drugs versus combinations of drugs with multiple targets: preclinical and clinical evidence for the treatment or prevention of epilepsy;Löscher;Front. Pharmacol.,2021

5. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the akt pathway in type 2 diabetic patients;Brasnyó;Br. J. Nutr.,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the delivery of anticancer drugs by nanoparticles and chitosan-based nanoparticles;International Journal of Pharmaceutics: X;2024-12

2. PM2.5-induced cellular senescence drives brown adipose tissue impairment in middle-aged mice;Ecotoxicology and Environmental Safety;2024-06

3. Fisetin nanoparticles based on cells cycle and apoptosis intervention for the treatment of lymphoma and leukemia;International Journal of Pharmaceutics;2024-04

4. New imidazole-2-thiones linked to acenaphythylenone as dual DNA intercalators and topoisomerase II inhibitors: structural optimization, docking, and apoptosis studies;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-03-15

5. Overcoming Breast Cancer Resistance to Targeted, Chemo-, and Immuno Therapy: Mechanisms and Strategies to Overcome Resistance and Facilitate Drug Development;Interdisciplinary Cancer Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3